目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 27)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
FIGURE 1 AMNIOTIC PRODUCTS MARKET SEGMENTATION
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 31)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.2.1 GROWTH FORECAST
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 6 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.5.1 COVID-19-SPECIFIC ASSUMPTIONS
2.6 LIMITATIONS
2.7 RISK ASSESSMENT
2.8 GROWTH RATE ASSUMPTIONS
2.9 COVID-19 ECONOMIC ASSESSMENT
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY

3 EXECUTIVE SUMMARY (Page No. - 45)
FIGURE 10 AMNIOTIC PRODUCTS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 11 AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 12 AMNIOTIC PRODUCTS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 13 AMNIOTIC PRODUCTS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 48)
4.1 AMNIOTIC PRODUCTS MARKET OVERVIEW
FIGURE 14 GROWING TARGET PATIENT POPULATION TO DRIVE MARKET GROWTH
4.2 AMNIOTIC PRODUCTS MARKET, BY TYPE (2021-2026)
FIGURE 15 AMNIOTIC MEMBRANES SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
4.3 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY TYPE AND COUNTRY (2020)
FIGURE 16 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN AMNIOTIC PRODUCTS MARKET IN 2020
4.4 AMNIOTIC PRODUCTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 US AND UK TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 51)
5.1 INTRODUCTION
FIGURE 18 AMNIOTIC PRODUCTS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growth in the target patient population
TABLE 1 GLOBAL PREVALENCE OF DIABETES
5.2.1.2 Rising incidence of burn injuries
5.2.1.3 Awareness programs for wound care treatment and management
TABLE 2 WOUND CARE AWARENESS INITIATIVES
5.2.1.4 Rising venture capital investments and government funding
TABLE 3 FUNDING FOR REGENERATIVE MEDICINE RESEARCH BY THE NIH UNDER THE 21ST CENTURY CURES ACT
FIGURE 19 ARTICLES RELATED TO AMNIOTIC PRODUCTS PUBLISHED FROM 2010 TO 2020
5.2.1.5 Increasing number of traumatic wounds
5.2.1.6 Growing number of amniotic membrane transplantations
TABLE 4 NO. OF AMNIOTIC MEMBRANE TRANSPLANTATIONS PERFORMED IN UNIVERSITY EYE HOSPITAL TÜBINGEN, GERMANY
5.2.1.7 Increasing number of ophthalmology, cosmetic, and orthopedic surgeries
5.2.2 OPPORTUNITIES
5.2.2.1 Emerging economies
TABLE 5 STRATEGIC DEVELOPMENTS IN THE ASIA PACIFIC
5.2.2.2 Implementation of the 21st Century Cures Act (US)
5.2.2.3 Increasing demand for stem cell research and regenerative medicine
FIGURE 20 STEM CELL RESEARCH FUNDING IN THE LAST 10 YEARS
TABLE 6 NIH FUNDING FOR CELL-BASED RESEARCH, 2016-2021 (USD MILLION)
5.2.3 CHALLENGES
5.2.3.1 Complications and limitations associated with the use of amniotic membranes
5.3 RANGES/SCENARIOS
5.3.1 AMNIOTIC PRODUCTS MARKET
FIGURE 21 PESSIMISTIC SCENARIO
FIGURE 22 OPTIMISTIC SCENARIO
FIGURE 23 REALISTIC SCENARIO
5.4 COVID-19 IMPACT ON THE AMNIOTIC PRODUCTS MARKET
5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.5.1 REVENUE SHIFT & REVENUE POCKETS FOR AMNIOTIC PRODUCT MANUFACTURERS
5.5.2 REVENUE SHIFT FOR THE AMNIOTIC PRODUCTS MARKET
5.6 PRICING ANALYSIS
TABLE 7 PRICES OF AMNIOTIC PRODUCTS
5.7 SUPPLY CHAIN ANALYSIS
FIGURE 24 DIRECT DISTRIBUTION: A STRATEGY PREFERRED BY PROMINENT COMPANIES
5.8 VALUE CHAIN ANALYSIS
FIGURE 25 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING THE DEVELOPMENT PHASE
5.9 ECOSYSTEM ANALYSIS
5.9.1 ROLE IN THE ECOSYSTEM
TABLE 8 ROLE OF KEY PLAYERS IN THE ECOSYSTEM
FIGURE 26 KEY PLAYERS IN THE AMNIOTIC PRODUCTS ECOSYSTEM
5.10 TECHNOLOGY ANALYSIS
5.11 PATENT ANALYSIS
5.12 TRADE ANALYSIS
TABLE 9 IMPORT DATA FOR EXTRACTS OF GLANDS OR OTHER ORGANS OR OF THEIR SECRETIONS FOR ORGANOTHERAPEUTIC USE, BY COUNTRY, 2016-2020 (USD MILLION)
TABLE 10 EXPORT DATA FOR EXTRACTS OF GLANDS OR OTHER ORGANS OR OF THEIR SECRETIONS FOR ORGANOTHERAPEUTIC USE, BY COUNTRY, 2016-2020 (USD MILLION)
5.13 REGULATORY LANDSCAPE
5.13.1 NORTH AMERICA
5.13.2 EUROPE
5.13.3 EMERGING COUNTRIES
5.14 PORTER’S FIVE FORCES ANALYSIS
TABLE 11 PORTER’S FIVE FORCES ANALYSIS
5.14.1 INTENSITY OF COMPETITIVE RIVALRY
5.14.2 BARGAINING POWER OF SUPPLIERS
5.14.3 BARGAINING POWER OF BUYERS
5.14.4 THREAT OF SUBSTITUTES
5.14.5 THREAT OF NEW ENTRANTS

6 AMNIOTIC PRODUCTS MARKET, BY TYPE (Page No. - 73)
6.1 INTRODUCTION
6.2 PRIMARY NOTES
TABLE 12 AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 13 AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
6.3 AMNIOTIC MEMBRANES
TABLE 14 AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 15 AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 16 AMNIOTIC MEMBRANES MARKET, BY REGION, 2017-2019 (USD MILLION)
TABLE 17 AMNIOTIC MEMBRANES MARKET, BY REGION, 2020-2026 (USD MILLION)
6.3.1 CRYOPRESERVED AMNIOTIC MEMBRANES
6.3.1.1 Cryopreserved amniotic membranes will dominate the amniotic membranes market during the forecast period
TABLE 18 CRYOPRESERVED AMNIOTIC MEMBRANES MARKET, BY REGION, 2017-2019 (USD MILLION)
TABLE 19 CRYOPRESERVED AMNIOTIC MEMBRANES MARKET, BY REGION, 2020-2026 (USD MILLION)
6.3.2 DEHYDRATED AMNIOTIC MEMBRANES
6.3.2.1 Logistical advantages of dehydrated amniotic membranes over cryopreserved amniotic membranes to drive market growth
TABLE 20 DEHYDRATED AMNIOTIC MEMBRANES MARKET, BY REGION, 2017-2019 (USD MILLION)
TABLE 21 DEHYDRATED AMNIOTIC MEMBRANES MARKET, BY REGION, 2020-2026 (USD MILLION)
6.4 AMNIOTIC SUSPENSIONS
6.4.1 ANTI-INFLAMMATORY AND ANTIMICROBIAL PROPERTIES OF AMNIOTIC SUSPENSIONS TO DRIVE MARKET GROWTH
TABLE 22 AMNIOTIC SUSPENSIONS MARKET, BY REGION, 2017-2019 (USD MILLION)
TABLE 23 AMNIOTIC SUSPENSIONS MARKET, BY REGION, 2020-2026 (USD MILLION)

7 AMNIOTIC PRODUCTS MARKET, BY APPLICATION (Page No. - 81)
7.1 INTRODUCTION
7.2 PRIMARY NOTES
TABLE 24 AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 25 AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
7.3 WOUND CARE
7.3.1 WOUND CARE IS THE LARGEST APPLICATION SEGMENT OF THE AMNIOTIC PRODUCTS MARKET
TABLE 26 AMNIOTIC PRODUCTS MARKET FOR WOUND CARE, BY REGION, 2017-2019 (USD MILLION)
TABLE 27 AMNIOTIC PRODUCTS MARKET FOR WOUND CARE, BY REGION, 2020-2026 (USD MILLION)
7.4 ORTHOPEDICS
7.4.1 BENEFITS OFFERED BY AMNIOTIC PRODUCTS FOR ORTHOPEDIC APPLICATIONS TO DRIVE MARKET GROWTH
TABLE 28 AMNIOTIC PRODUCTS MARKET FOR ORTHOPEDICS, BY REGION, 2017-2019 (USD MILLION)
TABLE 29 AMNIOTIC PRODUCTS MARKET FOR ORTHOPEDICS, BY REGION, 2020-2026 (USD MILLION)
7.5 OPHTHALMOLOGY
7.5.1 LIGHTWEIGHT, THIN, AND ELASTIC NATURE OF AMNIOTIC MEMBRANES MAKES THEM SUITABLE FOR USE IN OPHTHALMOLOGY
TABLE 30 AMNIOTIC PRODUCTS MARKET FOR OPHTHALMOLOGY, BY REGION, 2017-2019 (USD MILLION)
TABLE 31 AMNIOTIC PRODUCTS MARKET FOR OPHTHALMOLOGY, BY REGION, 2020-2026 (USD MILLION)
7.6 OTHER APPLICATIONS
TABLE 32 AMNIOTIC PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2017-2019 (USD MILLION)
TABLE 33 AMNIOTIC PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2020-2026 (USD MILLION)

8 AMNIOTIC PRODUCTS MARKET, BY END USER (Page No. - 89)
8.1 INTRODUCTION
TABLE 34 AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 35 AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
8.2 HOSPITALS & AMBULATORY SURGERY CENTERS
8.2.1 HOSPITALS & ASCS FORM THE LARGEST END-USER SEGMENT OF THE AMNIOTIC PRODUCTS MARKET
TABLE 36 PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED IN THE US
TABLE 37 AMNIOTIC PRODUCTS MARKET FOR HOSPITALS & ASCS, BY REGION, 2017-2019 (USD MILLION)
TABLE 38 AMNIOTIC PRODUCTS MARKET FOR HOSPITALS & ASCS, BY REGION, 2020-2026 (USD MILLION)
8.3 OTHER END USERS
TABLE 39 AMNIOTIC PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2017-2019 (USD MILLION)
TABLE 40 AMNIOTIC PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2020-2026 (USD MILLION)

9 AMNIOTIC PRODUCTS MARKET, BY REGION (Page No. - 95)
9.1 INTRODUCTION
TABLE 41 AMNIOTIC PRODUCTS MARKET, BY REGION, 2017-2019 (USD MILLION)
TABLE 42 AMNIOTIC PRODUCTS MARKET, BY REGION, 2020-2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET SNAPSHOT
TABLE 43 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
TABLE 44 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 45 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 46 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 47 NORTH AMERICA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 48 NORTH AMERICA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 49 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 50 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 51 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 52 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominates the North American amniotic products market
TABLE 53 US: KEY MACROINDICATORS
TABLE 54 US: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 55 US: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 56 US: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 57 US: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 58 US: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 59 US: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 60 US: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 61 US: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising prevalence of target diseases to drive market growth
TABLE 62 CANADA: KEY MACROINDICATORS
TABLE 63 CANADA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 64 CANADA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 65 CANADA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 66 CANADA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 67 CANADA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 68 CANADA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 69 CANADA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 70 CANADA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
9.3 EUROPE
TABLE 71 EUROPE: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
TABLE 72 EUROPE: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 73 EUROPE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 74 EUROPE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 75 EUROPE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 76 EUROPE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 77 EUROPE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 78 EUROPE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 79 EUROPE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 80 EUROPE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
9.3.1 UK
9.3.1.1 The UK accounted for the largest share of the European amniotic products market in 2020
TABLE 81 UK: KEY MACROINDICATORS
TABLE 82 UK: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 83 UK: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 84 UK: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 85 UK: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 86 UK: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 87 UK: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 88 UK: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 89 UK: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 Increasing incidence of diabetes to drive market growth in Germany
TABLE 90 GERMANY: KEY MACROINDICATORS
TABLE 91 GERMANY: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 92 GERMANY: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 93 GERMANY: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 94 GERMANY: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 95 GERMANY: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 96 GERMANY: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 97 GERMANY: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 98 GERMANY: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Rising government support to drive the demand for amniotic products in France
TABLE 99 FRANCE: KEY MACROINDICATORS
TABLE 100 FRANCE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 101 FRANCE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 102 FRANCE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 103 FRANCE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 104 FRANCE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 105 FRANCE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 106 FRANCE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 107 FRANCE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
9.3.4 REST OF EUROPE
TABLE 108 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP)
TABLE 109 ROE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 110 ROE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 111 ROE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 112 ROE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 113 ROE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 114 ROE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 115 ROE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 116 ROE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 28 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET SNAPSHOT
TABLE 117 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
TABLE 118 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 119 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 120 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 121 ASIA PACIFIC: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 122 ASIA PACIFIC: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 123 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 124 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 125 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 126 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
9.4.1 CHINA
9.4.1.1 China to dominate the Asia Pacific amniotic products market during the forecast period
TABLE 127 CHINA: KEY MACROINDICATORS
TABLE 128 CHINA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 129 CHINA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 130 CHINA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 131 CHINA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 132 CHINA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 133 CHINA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 134 CHINA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 135 CHINA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Growing geriatric population to drive market growth in Japan
TABLE 136 JAPAN: KEY MACROINDICATORS
TABLE 137 JAPAN: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 138 JAPAN: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 139 JAPAN: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 140 JAPAN: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 141 JAPAN: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 142 JAPAN: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 143 JAPAN: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 144 JAPAN: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
9.4.3 REST OF ASIA PACIFIC
TABLE 145 ROAPAC: DIABETES PREVALENCE (% OF POPULATION AGED 20-79), BY COUNTRY, 2019
TABLE 146 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 147 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 148 ROAPAC: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 149 ROAPAC: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 150 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 151 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 152 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 153 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET GROWTH
TABLE 154 LATIN AMERICA: DIABETES PREVALENCE (% OF POPULATION AGED 20-79), BY COUNTRY, 2019
TABLE 155 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 156 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 157 LATIN AMERICA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 158 LATIN AMERICA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 159 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 160 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 161 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 162 LATIN AMERICA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 SIGNIFICANT GROWTH IN HEALTHCARE INFRASTRUCTURE AND GOVERNMENT INITIATIVES TO FAVOR MARKET GROWTH
TABLE 163 MIDDLE EAST & AFRICA: DIABETES PREVALENCE (% OF POPULATION AGED 20-79), BY COUNTRY, 2019
TABLE 164 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 165 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 166 MIDDLE EAST & AFRICA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2017-2019 (USD MILLION)
TABLE 167 MIDDLE EAST & AFRICA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020-2026 (USD MILLION)
TABLE 168 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
TABLE 169 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 170 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2017-2019 (USD MILLION)
TABLE 171 MIDDLE EAST & AFRICA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 147)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 172 OVERVIEW OF STRATEGIES ADOPTED BY KEY AMNIOTIC PRODUCT MARKET PLAYERS
10.3 REVENUE SHARE ANALYSIS
FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN THE AMNIOTIC PRODUCTS MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 30 AMNIOTIC PRODUCTS MARKET SHARE ANALYSIS, 2020
TABLE 173 AMNIOTIC PRODUCTS MARKET: DEGREE OF COMPETITION (2020)
10.5 COMPANY EVALUATION QUADRANT
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 31 AMNIOTIC PRODUCTS MARKET: COMPANY EVALUATION QUADRANT (2020)
10.6 COMPANY EVALUATION QUADRANT: SMES/START-UPS
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 32 AMNIOTIC PRODUCTS MARKET: COMPANY EVALUATION QUADRANT FOR SMES & START-UPS (2020)
10.7 COMPETITIVE SCENARIO
10.7.1 DEALS
TABLE 174 DEALS
10.7.2 PRODUCT LAUNCHES & APPROVALS
TABLE 175 PRODUCT LAUNCHES & APPROVALS
10.7.3 OTHER DEVELOPMENTS
TABLE 176 OTHER DEVELOPMENTS
10.8 COMPANY FOOTPRINT ANALYSIS
TABLE 177 COMPANY FOOTPRINT ANALYSIS
TABLE 178 COMPANY PRODUCT FOOTPRINT
TABLE 179 COMPANY REGIONAL FOOTPRINT

11 COMPANY PROFILES (Page No. - 161)
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View)*
11.1.1 MIMEDX
TABLE 180 MIMEDX: BUSINESS OVERVIEW
FIGURE 33 MIMEDX: COMPANY SNAPSHOT (2020)
11.1.2 SMITH & NEPHEW PLC
TABLE 181 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
FIGURE 34 SMITH & NEPHEW: COMPANY SNAPSHOT (2020)
11.1.3 ORGANOGENESIS INC.
TABLE 182 ORGANOGENESIS INC.: BUSINESS OVERVIEW
FIGURE 35 ORGANOGENESIS INC.: COMPANY SNAPSHOT (2020)
11.1.4 INTEGRA LIFESCIENCES
TABLE 183 INTEGRA LIFESCIENCES: BUSINESS OVERVIEW
FIGURE 36 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2020)
11.1.5 STRYKER
TABLE 184 STRYKER: BUSINESS OVERVIEW
FIGURE 37 STRYKER: COMPANY SNAPSHOT (2020)
11.1.6 APPLIED BIOLOGICS
TABLE 185 APPLIED BIOLOGICS: BUSINESS OVERVIEW
11.1.7 CELULARITY INC.
TABLE 186 CELULARITY INC.: BUSINESS OVERVIEW
11.1.8 KATENA PRODUCTS, INC.
TABLE 187 KATENA PRODUCTS, INC.: BUSINESS OVERVIEW
11.1.9 LUCINA BIOSCIENCES
TABLE 188 LUCINA BIOSCIENCES: BUSINESS OVERVIEW
11.1.10 NEXT BIOSCIENCES
TABLE 189 NEXT BIOSCIENCES: BUSINESS OVERVIEW
11.1.11 SKYE BIOLOGICS HOLDINGS, LLC
TABLE 190 SKYE BIOLOGICS HOLDINGS, LLC: BUSINESS OVERVIEW
11.1.12 SURGENEX
TABLE 191 SURGENEX: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 TISSUETECH, INC.
11.2.2 VENTRIS MEDICAL, LLC
11.2.3 STIMLABS LLC
11.2.4 VIVEX BIOLOGICS
11.2.5 LIFECELL INTERNATIONAL PVT. LTD.
11.2.6 NUVISION BIOTHERAPIES LTD
11.2.7 GENESIS BIOLOGICS
11.2.8 SURGILOGIX
11.2.9 TIDES MEDICAL
11.2.10 ORTHOFIX MEDICAL INC.
11.2.11 ALLOSOURCE
11.2.12 MERAKRIS THERAPEUTICS
11.2.13 MTF BIOLOGICS
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

12 APPENDIX (Page No. - 198)
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS